Evidence map›Paper›PMID 33119310›Full record

ArticleNano letters2020

Nanoreporter of an Enzymatic Suicide Inactivation Pathway.

Zvi Yaari, Justin M Cheung, Hanan A Baker, Rune S Frederiksen, Prakrit V Jena, Christopher P Horoszko, Fang Jiao, Simon Scheuring, Minkui Luo, Daniel A Heller

Open access · greenAbstract read
In one paragraph

Article in Nano letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Near-Infrared Fluorescent Single-Walled Carbon Nanotubes for Biosensing.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Biosensing with Fluorescent Carbon Nanotubes.Angewandte Chemie (International ed. in English) · 2022
    Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Zvi YaariMemorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Justin M CheungMemorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Hanan A BakerMemorial Sloan Kettering Cancer Center, New York, New York 10065, United States.ORCID 0000-0001-6305-5875
Rune S FrederiksenMemorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Prakrit V JenaMemorial Sloan Kettering Cancer Center, New York, New York 10065, United States.ORCID 0000-0001-5493-3058
Christopher P HoroszkoMemorial Sloan Kettering Cancer Center, New York, New York 10065, United States.ORCID 0000-0003-2344-4707
Fang JiaoDepartment of Physiology and Biophysics, Weill Cornell Medicine, 1300 York Avenue, New York, New York 10065, United States.
Simon ScheuringDepartment of Physiology and Biophysics, Weill Cornell Medicine, 1300 York Avenue, New York, New York 10065, United States.ORCID 0000-0003-3534-069X
Minkui LuoMemorial Sloan Kettering Cancer Center, New York, New York 10065, United States.ORCID 0000-0001-7409-7034
Daniel A HellerMemorial Sloan Kettering Cancer Center, New York, New York 10065, United States.ORCID 0000-0002-6866-0000
Memorial Sloan Kettering Cancer Center · USCornell University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
CANCER PHARMACOLOGYT32CA062948 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI LORRAINE J GUDAS · 1994 to 2026
$12.1M
Interrogating Protein Methyltransferases with Integrated ApproachesR35GM131858 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI Minkui Luo · 2019 to 2026
$6.3M
Enabling physical stimuli in the study of structural dynamics: The sensory ion channelsDP1AT010874 · NCCIH · WEILL MEDICAL COLL OF CORNELL UNIV · PI SCHEURING, SIMON · 2019 to 2023
$5.9M
P-selectin-Mediated Targeting of PI3K Nanomedicines to the Tumor MicroenvironmentR01CA215719 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI HELLER, DANIEL ALAN · 2018 to 2022
$3.1M
Tumor-Selective Delivery Approaches for MedulloblastomaR01NS116353 · NINDS · SLOAN-KETTERING INST CAN RESEARCH · PI HELLER, DANIEL ALAN, RAJU, PRAVEEN B. · 2020 to 2024
$3.1M
Transient Metabolite Detection for Single-Cell Metabolomics and DiagnosticsDP2HD075698 · NICHD · SLOAN-KETTERING INST CAN RESEARCH · PI HELLER, DANIEL ALAN · 2012 to 2012
$2.7M
High-speed atomic force microscopy with microsecond time resolution for the study of channels and transportersR01NS110790 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Simon Scheuring · 2019 to 2026
$2.4M
Renal tubule-specific nanotherapeutics for acute kidney injuryR01DK114321 · NIDDK · SLOAN-KETTERING INST CAN RESEARCH · PI HELLER, DANIEL ALAN, JAIMES, EDGAR A · 2018 to 2020
$796k
NCCIH NIH HHS DP1 AT010874NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA215719NCI NIH HHS T32 CA062948NICHD NIH HHS DP2 HD075698NIDDK NIH HHS R01 DK114321NIGMS NIH HHS R35 GM131858NIGMS NIH HHS T32 GM007739NINDS NIH HHS R01 NS110790NINDS NIH HHS R01 NS116353
6 · The paper itself

Abstract

Enzymatic suicide inactivation, a route of permanent enzyme inhibition, is the mechanism of action for a wide array of pharmaceuticals. Here, we developed the first nanosensor that selectively reports the suicide inactivation pathway of an enzyme. The sensor is based on modulation of the near-infrared fluorescence of an enzyme-bound carbon nanotube. The nanosensor responded selectively to substrate-mediated suicide inactivation of the tyrosinase enzyme via bathochromic shifting of the nanotube emission wavelength. Mechanistic investigations revealed that singlet oxygen generated by the suicide inactivation pathway induced the response. We used the nanosensor to quantify the degree of enzymatic inactivation by measuring response rates to small molecule tyrosinase modulators. This work resulted in a new capability of interrogating a specific route of enzymatic death. Potential applications include drug screening and hit-validation for compounds that elicit or inhibit enzymatic inactivation and single-molecule measurements to assess population heterogeneity in enzyme activity.

Indexed as

Monophenol MonooxygenaseNanotubes, CarbonFluorescenceHumansKineticsNanotechnologyMonophenol MonooxygenaseNanotubes, CarbonDrug developmentDrug screeningEnzymologyHigh throughput assayReactive oxygen species

Identifiers

PMID33119310
PMCPMC8177003
OpenAlexW3096736439

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.